Amazon Is Now Offering Novo Nordisk's Wegovy Pill in Its Pharmacy. Here's How That Could Affect Hims & Hers, WW International, and GoodRx Holdings.
2026-02-05 20:35:00 ET
The headline-grabbing battle in the GLP-1 space pits pharmaceutical giants Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) against each other. That makes sense, since they both make GLP-1 drugs.
However, another battle is brewing that could be even larger, as Amazon (NASDAQ: AMZN) starts selling GLP-1 pills, competing with sellers like Hims & Hers (NYSE: HIMS) , WW International (NASDAQ: WW) , and GoodRx (NASDAQ: GDRX) .
Up until 2026, GLP-1 weight loss drugs were only available in injection form. The first company to market was Novo Nordisk with its Wegovy drug. However, Eli Lilly's Mounjaro and Zepbound quickly took the lead after introducing their injectable versions.
NASDAQ: WW
WW Trading
5.26% G/L:
$22.83 Last:
98,740 Volume:
$22.22 Open:
